Compare GDRX & FLGT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GDRX | FLGT |
|---|---|---|
| Founded | 2011 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Retail: Computer Software & Peripheral Equipment | Medical Specialities |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 868.9M | 867.4M |
| IPO Year | 2020 | 2016 |
| Metric | GDRX | FLGT |
|---|---|---|
| Price | $2.24 | $14.77 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 10 | 3 |
| Target Price | $3.86 | ★ $28.33 |
| AVG Volume (30 Days) | ★ 3.4M | 607.9K |
| Earning Date | 05-26-2026 | 06-01-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 125.00 | N/A |
| EPS | ★ 0.09 | N/A |
| Revenue | ★ $796,853,000.00 | $18,730,000.00 |
| Revenue This Year | N/A | $10.66 |
| Revenue Next Year | $5.75 | $12.17 |
| P/E Ratio | $24.56 | ★ N/A |
| Revenue Growth | ★ 0.57 | N/A |
| 52 Week Low | $1.77 | $13.46 |
| 52 Week High | $5.61 | $31.04 |
| Indicator | GDRX | FLGT |
|---|---|---|
| Relative Strength Index (RSI) | 47.39 | 25.46 |
| Support Level | $2.11 | $13.46 |
| Resistance Level | $2.59 | $22.97 |
| Average True Range (ATR) | 0.15 | 0.96 |
| MACD | 0.02 | -0.14 |
| Stochastic Oscillator | 62.55 | 11.84 |
GoodRx Holdings Inc is a consumer-focused digital healthcare platform that aims to lower the cost of healthcare in the United States. It operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and provides access to negotiated prices through codes that can be used to save money on prescriptions across the United States. GoodRx generates revenue from core business from pharmacy benefit managers (PBMs) that manage formularies and prescription transactions including establishing pricing between consumers and pharmacies. It also offers various healthcare products and services, including pharma manufacturer solutions, subscriptions, and telehealth services.
Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. The company is engaged in laboratory services business and a therapeutic development business. The laboratory services business which generates key revenue includes, technical laboratory services and professional interpretation of laboratory results by licensed physicians. Its therapeutic development business is focused on developing drug candidates for treating a broad range of cancers. The geographical segments are the United States, which generates the vast majority of the revenue; and Foreign.